SCHEMBL14855593

SCHEMBL14855593

O=CN(c1ccccc1)C1CCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.41
MITF O75030 1/20 0.41
RAB9A P51151 1/20 0.41
PAX8 Q06710 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADH1A P07327 6/20 0.39
ADH1C P00326 4/20 0.39
ESR1 P03372 1/20 0.38
ADH4 P08319 1/20 0.37
CYP2A6 P11509 1/20 0.36
KCNA3 P22001 1/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
HTT P42858 1/20 0.35
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14855772 0.98 TRPM8 (0.44) TRPM8ALDH1A1KDM4EMEN1KMT2A
SCHEMBL14855822 0.96 TRPM8 (0.46) TRPM8ALDH1A1KDM4EMEN1KMT2A
SCHEMBL3245978 0.96 TRPM8 (0.46) TRPM8ALDH1A1KDM4EMEN1KMT2A
SCHEMBL3245656 0.94 HTT (0.36) TRPM8ALDH1A1KDM4EMEN1KMT2A
SCHEMBL4136645 0.85 SLC6A4 (0.43) MEN1KMT2A
SCHEMBL15284332 0.82 HTR2A (0.49) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL15284825 0.81 ATM (0.48) ALDH1A1HTTATM
SCHEMBL28304677 0.80 GAA (0.34) TRPM8ALDH1A1HTTATM
SCHEMBL28213143 0.78 LTA4H (0.40) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL4118370 0.77 CYP2C9 (0.40) ALDH1A1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US disclosed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE PPARG, PPARA, PPARD TRPM8 845/4885ALDH1A1 1612/4885KDM4E 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.